Women and Parkinson’s: “My medication only works three weeks out of four”
Women and Parkinson's
Author: Omotola ThomasPublished: 14 November 2019
Prep: Cook: Serves:
In the second in our Women and Parkinson’s series, UK advocate and blogger Omotola Thomas describes the impact menstruation has on her symptoms. From facing heightened emotions that go “way beyond normal PMS”, to struggling to get up and care for her family – her account sheds light on some of the unique challenges faced by women with Parkinson’s
I noticed a twitch in my finger in 2010, but I wasn’t diagnosed with Parkinson’s until six years later. I was 35. When I was first diagnosed, I didn’t even think about the connection between Parkinson’s disease and women. I wasn’t told anything – I didn’t know that it could even be a ‘thing’.
It wasn’t until I took part in the women’s conference, Parkinson’s Eve, that I overheard a woman say: “We all know our medication only works three weeks out of four.” She was implying that Parkinson’s medication is ineffective during a woman’s period. I couldn’t believe it. I went away and did some research of my own and found other women were saying the same thing.
From then on, I started to monitor my symptoms more closely over the month and noticed a correlation: my Parkinson’s symptoms were far worse, and my medication less effective, on the days that fell before and during my period.
During that particular week, my gait constantly feels shuffled and I can’t walk properly. I can expect to feel slower, stiffer and more uncomfortable for at least two or three days – and that’s even after taking my medication. Though it’s difficult, especially as a mother, I don’t want to add to the cocktail of medications I already take or up my dosage, so I just try my best to manage.
The impact on motherhood
Then there’s the heightened emotions I feel. They go way beyond ‘normal’ PMS: I experience intense bouts of anxiety, depression and apathy.
The apathy, a symptom I particularly struggle with, has a significant impact on my role as a wife and a mother. Attending my children’s school events, doing household chores and sometimes simply being engaged in family life require a lot of effort. Even admitting this makes me feel guilty. Normal life shouldn’t require as much mental, emotional and physical effort as it sometimes does.
I used to feel confused by the sudden spikes in my motor and non-symptoms and didn’t know how to manage it. But being aware of why and when I am going to feel like this, ahead of time, now means I can prepare. I do this by trying to avoid situations that I know are going to upset me (though of course, sometimes this is out of my control) and exercising more.
Though – so far – the progression of my Parkinson’s has been relatively slow, during my period my worsened symptoms show me what a progressed diagnosis can look like, and it comes as a shock. The issue of intensified symptoms, and medication being less effective, is something that is just not spoken about – but knowledge is power. If women can be equipped early with the information on how Parkinson’s will impact them as women, they’ll be in a much better position to manage it.
This is still something I am trying to figure out myself, these fluctuating emotions and symptoms, but I plan to raise it with my neurologist next time I see them and open up the conversation. For now, I am just trying not to be too hard on myself.
Need to know: Omotola Thomas was born and raised in Nigeria, and now lives in Surrey, UK. She is a mother, blogger, Parkinson’s advocate and founder of ParkinStand– a platform designed to encourage people to fight Parkinson’s through physical and mental activities. She was diagnosed with the condition in 2016, at the age of 35.
Parkinson’s and menstruation: the facts
Approximately three million women have Parkinson’s worldwide
Over 3-5% of women diagnosed are under the age of 50
As many as 11 out of 12 pre-menopausal women feel worsened symptoms and the reduced effect of their medication in the days leading up to, and during, menstruation
Women with Parkinson’s say they struggle with the self-care needed during menstruation’s because of their worsened dexterity
Women and Parkinson’s: Our campaign
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Each week, we’ll be sharing the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
Billy Connolly “doing really well, funny as ever,” says wife
Pamela Stephenson gives an update on her husband’s condition
7 days ago
New insights on immune cell process and Parkinson’s disease
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…
Could analysing skin oil help diagnose Parkinson’s disease?
Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.
‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia
Dyskinesia is often caused by extended use of the common Parkinson’s medication levodopa – and can be debilitating for those with the condition. Now, researchers in the US may have found a way to suppress these involuntary movements through a protein called ‘sonic hedgehog’. To conduct their study, the team administered levodopa and sonic hedgehog agonists to rodent and non-human primate models of the condition. The results revealed that dopamine neurons use the protein to communicate with other neurons thought to play a role in levodopa-induced dyskinesia. Increased signalling of sonic hedgehog pathways was found to reduce this dyskinesia – providing “novel insight” into its formation and a “potential therapeutic solution”. “What we find,” wrote corresponding study author Professor Andreas Kottmann, “is that in several animal models, by replacing … dopamine together with agonists that mimic the effects of sonic hedgehog, these dyskinesias can be very much suppressed.”